STADA is a leading manufacturer of high-quality pharmaceuticals, both internationally and within the MENA region. Our products have been helping people for over 125 years, across 120 countries, where we are renowned for being a market-leading, reliable and trustworthy partner for all within the healthcare industry. Our key focus is on developing and providing products which help people protect and regain a dignified and able life.

Moreover with our generics, we ensure that everyday health remains affordable. At the core of STADA’s business ethos are the two key pillars of generics, including specialty pharmaceuticals and non-prescription consumer healthcare products.

STADA MENA has offices across 16 countries in the region, with KSA and the UAE representing 47% of that market share. Aside from STADA’s presence in the GCC, the company is also represented across the Levant, Iraq as well as North West and Sub Saharan Africa. Within the MENA region, STADA’s core focus is on Medical and Training, Sales and Marketing, Regulatory Affairs and Pharmacovigilance. Main brands in the region include Nizoral®, Versatis®, Tramal®, Proxen®, Radian® and several Natures Aid Products.

GETM (Global Export & Trade Markets)

  • Iraq
  • Libya
  • Jordan
  • Lebanon
  • Algeria
  • Marocco
  • Levant
  • North Africa
  • Tunisia
  • Egypt

GCC (Guld Cooperation Council):

  • Saudi Arabia
  • Qatar
  • Bahrain
  • United Arab Emirates
  • Kuwait
  • Oman

Other GETM Markets:

  • Myanmar
  • Singapore
  • Malaysia